Introduction
Acute myeloid leukemia (AML) is characterized by the clonal expansion of hematopoietic precursor cells that are blocked in their terminal differentiation (Griffin and Lo¨wenberg, 1986) . Unlike normal hematopoietic cells which are dependent upon the continuous presence of hematopoietic growth factors for survival and growth, AML cells often show a spontaneous proliferation in vitro even in serum-and cytokine-free culture medium (Young and Griffin, 1986; Reilly et al., 1989; Lo¨wenberg et al., 1993) . It has been demonstrated that in some AML specimens this spontaneous proliferation in vitro is due to an autocrine stimulation with cytokines like granulocyte-macrophage colony-stimulating factor (GM-CSF) (Young and Griffin, 1986) . However, most primary cultures of AML cells do not grow continuously in serum-free medium and die by apoptosis which can be prevented by adding cytokines or by culturing the AML cells on bone marrow-derived stroma cells (Bendall et al., 1994) . These data indicate that in most cases AML cells still need additional signals to survive and proliferate in vitro and suggest that similar signals are required to achieve the continuous growth of leukemia cells in AML patients in vivo.
Despite the factor dependence of most leukemia cells, several experiments implicate the acquisition of factor independence in the process of leukemogenesis. The first hint was the demonstration that the capacity of AML cells to proliferate in vitro in a factor-independent manner is associated with high aggressive AML (Lo¨w-enberg et al., 1993) . Secondly, abrogation of factor dependence of hematopoietic cells is associated in most cases analysed with the conversion to a malignant phenotype (Schrader and Crapper, 1983; Lang et al., 1985; Daley and Baltimore, 1988; Stocking et al., 1988) . Further studies revealed that at least two separate but interdependent events may be required to achieve factorindependent growth and leukemic transformation (Laker et al., 1987; Chang et al., 1989; Stocking et al., 1989) .
Several molecular events have been implicated in the abrogation of factor-dependent growth. It has been demonstrated that ectopic expression of an appropriate factor that is required by the factor-dependent cells for survival and proliferation abrogates their factor dependence by an autocrine loop (Lang et al., 1985; Laker et al., 1987) . This autocrine stimulation can even be achieved without secretion of the cytokine as demonstrated for a modified nonsecreted form of Interleukin 3 (IL-3) which confers factor-independent growth by intracellular binding of IL-3 to its receptor (Dunbar et al., 1989) . There is also evidence that an autocrine stimulation can occur by activation of the endogenous cytokine genes like IL-3 or GM-CSF after insertion of a transposable-like element or an intracisternal A-particle (IAP) provirus (Stocking et al., 1988; Du¨hrsen et al., 1990; Heberlein et al., 1990) .
Additional mechanisms involved in the abrogation of factor-dependent growth are the constitutive activation of hematopoietic growth factor receptors or their associated downstream signaling components. Overexpression of cytokine receptors like the IL-3 receptor or activating mutations in the common beta chain (b c ) that is shared with the receptors for IL-3, IL-5 and GM-CSF can contribute to factor-independent growth (Hannemann et al., 1995; Steelman et al., 1996; McCormack and Gonda, 1997; Prassolov et al., 2001) . In addition, induction of factor-independent growth has been demonstrated for several activated forms of receptor tyrosine kinases like fms (Wheeler et al., 1986 (Wheeler et al., , 1987 , trk (Katzav et al., 1989) and kit (Kitayama et al., 1996) , and cytoplasmic tyrosine kinases like src (Adkins et al., 1984; Pierce et al., 1984; Overell et al., 1987; Watson et al., 1987; Anderson et al., 1990; McCubrey et al., 1993; Chaturverdi et al., 1997) , abl (Cook et al., 1985; Pierce et al., 1985) , fps/fes (Meckling-Gill et al., 1992) and Jak2 (Laconique et al., 1997) . From these data, it is evident that ectopic expression of activated receptor and cytoplasmic tyrosine kinases can contribute to factor-independent growth and strongly suggest that tyrosine phosphorylation plays a crucial role in mediating those signals.
In this report, it was investigated whether an activation of endogenous tyrosine kinases occur in factor-independent mutants. By analysing the tyrosinephosphorylated proteins of 14 factor-independent mutants derived from the GM-CSF-dependent cell line TF-1, a constitutively tyrosine-phosphorylated protein of 60 kDa was detected in 11 mutants, which was subsequently identified as p60 c-Src . The detection of an increase in the expression and total activity of p60 c-Src in factor-independent mutants suggests a direct role of endogenous p60 c-Src in the abrogation of factor dependence.
Results
A protein of 60 kDa is constitutively tyrosinephosphorylated in several autonomous GM-CSFindependent TF-1 mutants In all, 14 autonomous GM-CSF-independent TF-1 mutants that do not secrete any detectable growthstimulating activity for TF-1 cells were analysed for tyrosine-phosphorylated proteins constitutively present in these cells. After immunoblotting of total cell lysates with anti-phosphotyrosine antibodies, a tyrosine-phosphorylated protein with an apparent molecular weight of 60 kDa (pp60) was detectable in different amounts in 11 out of 14 GM-CSF-independent TF-1 mutants (Figure 1, lanes 4-17) . High amounts of pp60 were observed in the mutants I10-1, I16-3 and I33-5 (Figure 1 , lanes 5, 7 and 9), moderate amounts in the mutants I15-3, I26-4 and II25 (Figure 1 , lanes 6, 8 and 10) and low amounts in the mutants I2b, II40C, IIING1-3, lanes 4, [11] [12] [13] [14] [15] [16] . This 60 kDa tyrosine-phosphorylated protein was not detectable in TF-1 cells grown in GM-CSF-containing medium (Medium) (Figure 1 , lane 1) or in starved TF-1 cells before or after stimulation with GM-CSF ( Figure 1, lanes 2 and 3) . In GM-CSF-stimulated TF-1 cells, p52
Shc which has an apparent molecular weight of 56 kDa in SDS gels becomes tyrosine-phosphorylated, as described previously (Ju¨cker et al., 1997a) .
The 60 kDa tyrosine-phosphorylated protein is p60 c-Src
The protein that was constitutively tyrosine-phosphorylated in several factor-independent mutants had an apparent molecular weight of 60 kDa (Figure 1 ). Since the tyrosine kinase Src has been implicated in the Figure 1 Detection of a constitutively tyrosine-phosphorylated protein of 60 kDa in GM-CSF-independent TF-1 mutants. Total cellular lysates from TF-1 cells (lanes 1-3) and from 14 GM-CSFindependent TF-1 mutants (lanes 4-17) were analysed by antiphosphotyrosine immunoblotting. TF-1 cells were grown in RPMI 1640 medium containing 10% FCS and recombinant human GM-CSF (lane 1). Sister cultures of TF-1 cells were starved for 18 h in medium without GM-CSF and lysed either directly (lane 2) or after stimulation with recombinant GM-CSF for 5 min (lane 3). All GM-CSF-independent mutants of TF-1 were grown in serumcontaining medium without GM-CSF. The locations of p52 Shc in GM-CSF-stimulated TF-1 cells (lane 3) and of a constitutively tyrosine-phosphorylated protein of 60 kDa (pp60) in several GM-CSF-independent TF-1 mutants (lanes 4-11 and 14-16) are indicated. p52
Shc has an apparent molecular weight of 56 kDa in SDS gels as described previously (Ju¨cker et al., 1997a) Increased Src kinase activity in factor-independent mutants S Horn et al abrogation of factor-dependent growth and has a molecular weight of 60 kDa, it was analysed whether pp60 is identical to p60 c-Src . The apparent size of pp60 detected after anti-phosphotyrosine immunoblotting in the GM-CSF-independent TF-1 mutant I16-3 is identical to the size of p60 c-Src detected after anti-Src immunoblotting (Figure 2a, lanes 1-3) . The identity of pp60 with p60
c-Src was then demonstrated by a depletion experiment with anti-Src antibodies. Immunoprecipitation of p60 c-Src with a monoclonal anti-Src antibody (mAb327) from the lysate of the factor-independent mutant I16-3 resulted in the depletion of pp60 (Figure 2b, lane 3) . As controls, the same immunoprecipitations were performed either with the anti-mouse Ig which were used to couple the anti-Src-antibodies to protein A sepharose ( Figure 2b , lane 2) or with a monoclonal antibody (MON-9.1) directed against the tyrosine kinase Fes (Figure 2b, lane 4) . In both control immunoprecipitations, pp60 was not depleted (Figure 2b, lanes 2 and 4) . The specific immunoprecipitation of pp60 with anti-Src antibodies, but not with anti-Fes antibodies, was also controlled by analysing the anti-Src and anti-Fes immunoprecipitates by phosphotyrosine immunoblotting (Figure 2b, lanes 6 and 7) .
Overexpression of c-src on the RNA and protein level After identification of pp60 as p60 c-Src in the factorindependent mutant I16-3, the amounts of tyrosinephosphorylated pp60 was compared in total cell lysates of the other factor-independent mutants with the amounts of tyrosine-phosphorylated p60 c-Src in anti-Src immunoprecipitates. There was a good correlation between increased tyrosine phosphorylation of pp60 in total cell lysates and in anti-Src immunoprecipitates, further underlining their identity (compare Figures 1 and 3a, upper part (P.Tyr)). Removal of the phosphotyrosine antibody probe and subsequent analysis of the blot with an anti-Src antibody showed that increased amounts of tyrosine-phosphorylated Src correlated with increased expression of p60 c-Src (Figure 3a , lower part (Src)). The increase in expression of p60 c-Src in the factorindependent mutants was confirmed by analysing total cell lysates with anti-Src antibodies (Figure 3b ). Equal loading was confirmed by stripping and reprobing with anti-MAP-kinase (ERK2) and anti-Shc antibodies. To quantitate the observed overexpression in more detail, serial dilutions of the protein extracts were analysed by anti-Src immunoblotting. These experiments revealed a 2.5-fold overexpression of p60 c-Src in the factorindependent cell lines I10-1, I16-3 and I33-5 (data not shown).
It was further analysed whether the increased expression of Src observed in factor-independent mutants was also detectable on the RNA level. Figure 3c shows the result of a Northern blot analysis after hybridization of 20 mg total RNA of the given cell lines with a 32 P-labeled human c-src cDNA probe. Increased amounts of c-src mRNA of 4.2 kb were detected in several factor-independent mutants in comparison to TF-1 cells (TF-1) or helper virus-infected TF-1 cells (TF-1 PAP10#5) (Figure 3c ). Those mutants with higher expression of p60 c-Src showed also higher amounts of c-src mRNA, that is, I3-1, I10-1, I-15-3, I-16-3, I23-1 and I33-5.
These data indicate an increase in the expression of c-src in several factor-independent mutants on the RNA and protein level. Increased kinase activity of p60 c-Src in several factor-independent TF-1 mutants
To analyse whether the increase in the expression of p60 c-Src in the factor-independent mutants is associated with an increase in Src activity, immune complex kinase assays were performed. The factor-independent mutants were starved for 18 h in medium without fetal calf serum to avoid any stimulatory activity provided by a factor in the serum. Starved TF-1 cells either unstimulated or after GM-CSF stimulation were used as controls. p60 c-Src was immunoprecipitated from each cell lysate, incubated with [g-32 P]ATP and the reaction products were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). As a measurement of Src activity, autophosphorylation of p60 c-Src was analysed. Gel slices containing 32 P-labeled Src were cut out from the gel and measured in a b-counter. The autoradiography of the gel and the amounts of 32 P-labeled p60 c-Src are shown in Figure 4a . In comparison to starved TF-1 cells, the kinase activity of p60 c-Src was increased in nine out of 12 factor-independent mutants, analysed (Figure 4, . A strong increase of p60 c-Src kinase activity of 8-12-fold was observed in the mutants I10-1 (8.8), I15-3 (8.9), I-16-3 (12.4) and I33-5 (11.4) and a moderate increase of 1.6-3.7-fold was detected in the mutants I2b (2.7), I26.4 (3.7), IIING1-3 (2.4), IIING1-8 (1.6) and IIING1-13 (2.6). Stimulation of TF-1 cells with GM-CSF resulted in a small increase of 0.2-0.5-fold of autophosphorylated p60 c-Src , indicating that GM-CSF can only weakly activate Src and not to levels detectable in several of the factor-independent mutants ( Figure 4 , lanes 1 and 2). Interestingly, the mutants with high Src activity are those with high Src expression, that is, I10-1, I15-3, I-16-3, I26-4 and I33-5. These data indicate an increase in total activity of p60 c-Src in several GM-CSF-independent mutants up to 12-fold and that increased Src activity correlates with increased expression of p60 c-Src .
Increased tyrosine phosphorylation of the Src substrate Sam68 in mutants with high Src activity
Whether the increased Src activity detected in several factor-independent mutants leads to an increased phosphorylation of Src substrates in these mutants was further analysed. The protein Sam68, which is a known substrate of p60 c-Src , was immunoprecipitated from TF-1 cells or from seven factor-independent mutants with low or high Src activity. As shown in Figure 4b , a higher tyrosine phosphorylation of Sam68 was detected in three out of four factor-independent mutants with high Src activity, that is, I10-1, I16-3 and I-33-5, compared to a virus-infected control clone of the GM-CSF-dependent parental TF-1 cells (TF-1 PAP10#5) and to three factor-independent mutants with low Src activity, that is, I2b, I26-4 and IIING1-13. It has been reported that abrogation of factor dependence by activated tyrosine kinases like v-src can induce an autocrine growth cycle (Anderson et al., 1990) . The mutants used in this study are autonomous mutants which do not secrete growth factors with a stimulating activity for the parental TF-1 cell line including GM-CSF or IL-3. However, this does not exclude the possibility of an intracellular stimulation of receptors by nonsecreted forms of growth factors as it has been shown for PDGF or IL-3 targeted for retention within the endoplasmic reticulum (Bejcek et al., 1989; Dunbar et al., 1989) . In addition, it has been shown that mutated forms of the b c of the GM-CSF receptor can become constitutively activated and contribute to factor-independent growth (Hannemann et al., 1995; McCormack and Gonda, 1997; Prassolov et al., 2001) . Therefore, it was analysed whether the GM-CSF-independent TF-1 mutants with an increased Src-kinase activity show an activation of the GM-CSF receptor and downstream signal transduction. After binding of GM-CSF to the a chain of the GM-CSF receptor, the signal-transducing b c becomes tyrosine-phosphorylated by Jak2 and triggers the activation of several downstream signaling molecules including STAT5 (Quelle et al., 1994; Mui et al., 1995) . As shown in Figure 5 , b c , Jak2 and STAT5 are not activated in the factor-independent mutants with high levels of c-Src activity, that is, I10-1, I15-3, I16-3, I26-4 and I33-5. However, the b c is constitutively tyrosine-phosphorylated in five factor-independent mutants, that is, III1-13, III2-3, IIING1-3, IIING1-8 and IIING1-25 ( Figure 5 , lanes 12-15 and 17) and STAT5 is constitutively activated in four mutants, that is, II40c, III2-3, lanes 11, 13, 15 and 17) . Mutants with activated b c and STAT5 did not show detectable tyrosine phosphorylation of Jak2 Figure 4 Increased activity of p60 c-Src and increased phosphorylation of the Src substrate Sam68 in factor-independent mutants. (a) Sister cultures of TF-1 cells were starved for 18 h in medium without GM-CSF and protein lysates were prepared either from unstimulated cells (lane 1) or from cells stimulated with recombinant GM-CSF for 5 min (lane 2). GM-CSF-independent mutants (lanes 3-14) were grown in serum-containing medium without GM-CSF and starved for 18 h in serum-free medium before protein lysates were prepared. p60 c-Src was immunoprecipitated from each lysate and an immune complex kinase assay with [g-32 P]ATP was performed as described in Materials and methods. The samples were separated in an SDS-PAGE and autophosphorylated Src was detected by autoradiography (lower part). Gel slices containing 32 P-labeled Src were cut out from the gel and quantitated in a b-counter (upper part). (b) Sam68 was immunoprecipitated from lysates of a vector-infected TF-1 control clone (TF1 PAP10#5) or from seven factor-independent mutants and analysed by anti-phosphotyrosine immunoblotting (P.Tyr). The locations of Sam68 and the immunoglobulin heavy chains (Ig) of the antibodies used for immunoprecipitation are indicated Figure 5 Constitutive activation of b c of the GM-CSF receptor and STAT5 in factor-independent mutants without increased Src activity. The b c of the GM-CSF receptor or Jak2 were immunoprecipitated from total cell lysates prepared from GM-CSFindependent mutants grown in medium without GM-CSF (lanes 4-17). TF-1 cells grown in GM-CSF-containing medium (lane 3) or sister cultures of starved TF-1 cells before (lane 1) or after GM-CSF stimulation (lane 2) were used as controls. The immunoprecipitates were analysed by anti-phosphotyrosine immunoblotting (P.Tyr). The same filter was reprobed with anti-b c or anti-Jak2 antibodies. Activation of STAT5 was analysed by an EMSA. Nuclear extracts from the indicated cells were prepared and an aliquot was incubated with an end-labeled oligonucleotide of the b-casein promotor containing the STAT5 binding site. The reaction mixtures were separated on a polyacrylamide gel and visualized by autoradiography Increased Src kinase activity in factor-independent mutants S Horn et al (lanes 4-17) . Further analysis of signaling events downstream of the GM-CSF receptor did not reveal increased tyrosine phosphorylation of the adapter protein Shc or increased kinase activity of the MAP-kinase Erk1/2 in factor-independent mutants with high Src activity, whereas GM-CSF stimulation resulted in activation of MAP-kinase activity in all mutants analysed (data not shown).
These data indicate that factor-independent mutants with an increase in total Src activity do not show activation of the GM-CSF receptor b c , Jak2, STAT5, Shc and MAP-kinase, thereby excluding GM-CSFmediated signal transduction as a target or cooperation partner for Src in these mutants.
Proliferation of factor-independent mutants is reduced by a Src kinase inhibitor
To obtain biological evidence that Src is necessary for the proliferation of the factor-independent mutants, inhibition studies with the Src kinase inhibitor PP2 were performed. It has been shown that PP2 or the closely related compound PP1 is a potent inhibitor of Src family kinases (Hanke et al., 1996; Nijhuis et al., 2002) . As shown in Figure 6 , proliferation of the parental cell line TF-1 was partially inhibited in a concentration-dependent manner after incubation with PP2 at 1 or 10 mm. In factor-independent mutants with high Src activity, that is, I15-3 and I33-5, or with low Src activity, that is, IIING1-8, a partial inhibition of proliferation was observed with 10 mm PP2 (Figure 6 ). Inhibition of Src kinase activity in the mutant I33-5 after treatment of the cells with 10 mm PP2 was confirmed in an immune complex kinase assay by analysing the autophosphorylation of immunoprecipitated p60 c-Src (data not shown). The effect of PP2 used at 1 mm showed a statistically significant growth inhibition on one of the two mutants with high Src activity, that is, I15-3, but not the other, that is, I33-5 (Figure 6 ). The factor-independent mutant IIING1-8 with low Src activity did not show any effect at 1 mm PP2. These data indicate that the parental TF-1 cell line as well as the factor-independent mutants are dependent on Src kinases for maximal proliferation.
Discussion
More than 200 factor-independent mutants have been established after retroviral infection from the GM-CSFdependent human erythroleukemia cell line TF-1 (Stocking et al., 1993) . A minority of these mutants (13%) secreted unidentified growth factors that supported the short-term survival and growth of TF-1 cells, suggesting the involvement of an autocrine mechanism in the abrogation of factor dependence in these mutants. However, the majority (87%) of factor-independent mutants did not release a growth-stimulatory activity and these mutants have been named 'autonomous mutants'. As an approach to identify activated proteins involved in the abrogation of factor dependence in these autonomous mutants, a detailed analysis of the tyrosinephosphorylated proteins of these cells was performed. The reason for this analysis was the high capability of protein tyrosine kinases to mediate factor-independent growth in hematopoietic cells, as it has been shown for several receptor and cytoplasmic tyrosine kinases (Adkins et al., 1984; Pierce et al., 1984 Pierce et al., , 1985 Cook et al., 1985; Wheeler et al., 1986; Overell et al., 1987; Watson et al., 1987; Katzav et al., 1989; Anderson et al., 1990; Meckling-Gill et al., 1992; McCubrey et al., 1993; Kitayama et al., 1996; Chaturverdi et al., 1997; Laconique et al., 1997) .
In this analysis, a constitutively tyrosine-phosphorylated protein of 60 kDa was detected in 11 out of 14 autonomous mutants of the GM-CSF-dependent cell line TF-1. This protein of 60 kDa was subsequently identified as the protein tyrosine kinase p60 c-Src . The kinase activity of p60 c-Src was increased up to 12-fold in the autonomous mutants compared to the parental TF-1 cells. Increased Src kinase activity in the mutants was at least partly due to the increased expression of the c-src gene, which was shown on the RNA and protein level. Further analysis of a known Src substrate, that is, Sam68, revealed a higher tyrosine phosphorylation of Sam68 in three out of four factor-independent mutants with high Src activity compared to parental TF-1 cells and to three factor-independent mutants with low Src activity. These data suggest that the increased activity of p60 c-Src observed in several factor-independent mutants is triggering downstream signaling events in these cells. Sam 68 is an RNA-binding protein that binds to Src and becomes tyrosine-phosphorylated by Src during mitosis (Fumagalli et al., 1994; Taylor and Shalloway, 1994 ). In addition, a possible role for Sam68 in the regulation of Figure 6 Inhibition of proliferation by the Src kinase inhibitor PP2. TF-1 cells and three GM-CSF-independent TF-1 mutants either with high Src activity, that is, I15-3 and I33-5, or with very low Src activity, that is, IIING 1-8, were incubated with the Src kinase inhibitor PP2. The percentage of viable cells after 3 days of culture in 1 or 10 mm PP2 is shown. Each bar represents the mean7s.d. of three separate cell cultures. Statistical analysis was performed by using Student's t-test. *Significant (P-value between 0.01 and 0.05), **Very significant (P-value between 0.001 and 0.01) Increased Src kinase activity in factor-independent mutants S Horn et al cell cycle progression has been described (Barlat et al., 1997) . Whether Sam68 is involved in the abrogation of factor-independent growth triggered by an activated Src kinase has to be analysed in further experiments.
The reason for the increased expression and activity of p60 c-Src in several factor-independent TF-1 clones is not clear. All mutants used in this study have been analysed by Southern blot experiments. During this analysis, a twofold amplification of the c-src gene was detected in one of the factor-independent mutants, that is, II25, which may explain the increased expression of p60 c-Src in these cells. In the other factor-independent mutants, an amplification or a rearrangement of the c-src locus was not detected (Horn and Ju¨cker, data not shown). However, this does not exclude the possibility that minor mutations like point mutations in the promoter region are responsible for the increased expression of the c-src gene. Another possibility which could have led to overexpression of Src is the integration of the retrovirus used in this study to increase the frequency of TF-1 cells to become growth factorindependent. Neither an integration of the retrovirus in the c-src locus nor aberrant c-src mRNAs which may have resulted from transcription of the retroviral promoter after integration in the c-src gene were detected. Even though these results argue against a role of the retrovirus in activation of c-src expression, they do not exclude the possibility that the virus has integrated outside the c-src locus or influences the expression of c-src by an indirect mechanism, for example, the activation of transcription factors.
Several mutations in different domains of Src including the SH3 domain, SH2 domain, kinase domain and regulatory domain at the c-terminus have been described to activate the kinase activity of Src (Kmiecik and Shalloway, 1987; Seidel-Dugan et al., 1992; Bjorge et al., 1995) . Therefore, the open reading frame of several c-src cDNA clones of the mutant I33-5 which showed high Src activity was sequenced. However, a mutation within the SH3 domain, SH2 domain, kinase domain or regulatory domain at the c-terminus of the c-src gene was not detected, thereby excluding an activation of Src by a mutation in these regions of this factor-independent mutant (Horn and Ju¨cker, data not shown).
It has been demonstrated by several laboratories that expression of activated forms of Src is able to abrogate factor dependence either by autocrine or nonautocrine mechanisms (Adkins et al., 1984; Pierce et al., 1984; Overell et al., 1987; Watson et al., 1987; Anderson et al., 1990; McCubrey et al., 1993; Chaturverdi et al., 1997) . The mutants used in this study were selected with respect to the absence of any growth-stimulatory activity in the conditioned medium for the parental TF-1 cells, suggesting that an autocrine stimulation by secreted growth factors does not occur in these mutants. However, it has been postulated that nonsecreted forms of factors can stimulate autocrine growth by interacting with its appropriate receptor intracellularly (Bejcek et al., 1989; Dunbar et al., 1989) . Therefore, a putative stimulation of the GM-CSF receptor was analysed in total cellular lysates. In the mutants with increased Src activity, tyrosine phosphorylation of the b c , which is the signal-transducing subunit of the GM-CSF, IL-3 and IL-5 receptors, was not detected, thereby excluding autocrine stimulation by these cytokines. Even though these data argue against an autocrine stimulation of the TF-1 mutants, we cannot exclude the possibility that the TF-1 mutants express a different cytokine and the appropriate cytokine receptor which are not expressed on the parental TF-1 cells, thereby stimulating the proliferation of the mutants.
During this analysis, a constitutive tyrosine phosphorylation of b c was detected in five factor-independent mutants with low Src kinase activity. Tyrosine phosphorylation of b c in these mutants correlated with activation of STAT5 which was not detectable in the mutants with high Src activity. Surprisingly, Jak2 was not activated in any mutant analysed, suggesting that another kinase mediates tyrosine phosphorylation of b c in these cells. These data suggest that increased Src activity in the factor-independent mutants does not trigger an intracellular or extracellular autocrine stimulation of the GM-CSF receptor. In contrast, five mutants with low Src kinase activity show constitutive GM-CSF receptor signaling which may have contributed to the factor-independent growth of those mutants.
An important question is whether Src has contributed to the factor independence of those mutants which show an increased Src expression and activity. It has been reported that overexpression of an unmutated c-src gene does not induce growth factor independence (Ostermeyer and Anderson, 1996) or transformation of cells (Shalloway et al., 1984; Johnson et al., 1985) . However, NIH3T3 cells overexpressing c-src show a more rounded and refractile morphology than normal NIH3T3 cells, and form small colonies in soft agar with reasonable efficiency (Shalloway et al., 1984) . Further analysis revealed that high expression of c-src induces focus formation of NIH3T3 cells and of primary chicken embryo fibroblasts, indicating that the level of Src expression is critical to achieve the observed biological effects (Johnson et al., 1985; Zhou and Duesberg, 1990) . A high enzymatic activity of Src was observed at least in four of the factor-independent mutants, that is, I10-1, I15-3, I16-3 and I33-5, which was increased up to 12-fold compared to the parental TF-1 cells. From these data, it seems possible that the increase in total activity of p60 c-Src has contributed to the factor-independent phenotype of these mutants. Since an increased expression of p60 c-Src does not seem to be sufficient to abrogate factor independence by itself, this may have occurred by activation of a second signaling event cooperating with p60 c-Src . It has been shown that overexpression of c-Src together with c-myc can induce anchorage-independent growth and enhanced focus formation . Overexpression of c-myc was not observed in the TF-1 mutants analysed (Horn and Ju¨cker, data not shown).
The Ras/Raf/MAP-kinase pathway has been implicated in mediating the antiapoptotic effects of GM-CSF or IL-3 (Kinoshita et al., 1995) . Ras plays a role in the oncogenic signal transduction by v-Src (Nori et al., 1991) and Ras is required for survival of factorindependent cells induced by v-Src (Odajima et al., 2000) . A constitutive activation of Raf-1 and MAPkinase (p42/p44) has been detected by Chao et al. (1997) in two nonautocrine factor-independent TF-1 mutants, whereas Gabert et al. (1994) did not detect an activated Raf/MAP-kinase pathway in six factor-independent TF-1 mutants. The MAP-kinase (p42/p44) activity of GM-CSF-dependent TF-1 cells and 12 factor-independent TF-1 mutants was analysed by an immune complex kinase assay. In all mutants analysed, low amounts of MAP-kinase activity was measured; however, only one out of 12 mutants, that is, III 2-3, showed an elevation of MAP-kinase activity in comparison with the parental TF-1 cell line. In contrast, stimulation of the cells with GM-CSF resulted in a strong stimulation of MAPkinase activity of all 12 mutants analysed (Horn and Ju¨cker, data not shown). From these data, it is unlikely that increased activation of the Ras/Raf/MAP-kinase pathway has contributed to the abrogation of factor dependence of our TF-1 mutants either in cooperation with or independently of activated c-Src except the mutant III 2-3.
The phosphatidylinositol-3 kinase (PI3-kinase) and one of its downstream effector proteins, the serine/threonine kinase Akt, are activated by a variety of cytokines including GM-CSF (Corey et al., 1993; Ju¨cker and Feldman, 1995; Klein et al., 2000) . The PI3-kinase/Akt signaling pathway has been implicated in tumorigenesis and is currently investigated as a possible molecular target for cancer therapy (Chang et al., 2003) . Expression of activated forms of Akt in IL-3-dependent hematopoietic cells did not abrogate factor dependence; however, Akt promoted the development of factorindependent growth and leukemogenesis in vivo and was constitutively activated in factor-independent cell clones derived from these mice (Karnauskas et al., 2003) . In our factor-independent TF-1 mutants, a weak constitutive activation of Akt was detected in one mutant, that is, I10-1, only, thereby excluding the involvement of the PI3-kinase/Akt signaling pathway in the abrogation of factor dependence of these TF-1 mutants, except the mutant I10-1 (data not shown).
To analyse whether the proliferation of the factorindependent mutants is dependent on the activity of Src kinases, the cells were treated with the Src kinase inhibitor PP2. Proliferation of the parental TF-1 cell line as well as three factor-independent mutants was reduced after treatment of the cells with 10 mm PP2, regardless of the activity of p60 c-Src in these cells. Treatment of the cells with 10 mm PP2 resulted in a partial growth inhibition of the parental TF-1 cells and a mutant with high Src activity, that is, I15-3, but no statistically significant inhibition was observed at this PP2 concentration in another mutant with high Src activity, that is, I33-5, or a mutant with low Src activity, that is, IIING1-8. The interpretation of the results is complicated by the fact that PP2 or its chemical analogous compound PP1 inhibit not only Src, but also other members of the Src kinase family, that is, Lyn, Lck and Fyn (Hanke et al., 1996; Nijhuis et al., 2002) . TF-1 cells express at least two other members of the Src family kinases, that is, Lyn and Yes, which are involved in GM-CSF-dependent signaling (Corey et al., 1993; Ju¨cker and Feldman, 1995) . Therefore, we cannot exclude the possibility that inhibition of other Src family kinases like Lyn and Yes is responsible for the reduced proliferation of the parental TF-1 cells or the factor-independent TF-1 mutants after PP2 treatment. The lower sensitivity of the factorindependent mutants I33-5 and IIING1-8 for inhibition by PP2 compared to the parental TF-1 cell line or to mutant I15-3 may be due to the activation of an Src kinase-independent signaling pathway, replacing the need for Src kinase-mediated signaling. Indeed, further analysis of mutant IIING1-8 revealed a constitutive activation of STAT5 ( Figure 5 ) and it has been shown that activation of STAT5 is not reduced by the Srckinase inhibitor PP1 (Nijhuis et al., 2002) .
In summary, our data indicate an increase in the expression and total activity of p60 c-Src in several GM-CSF-independent TF-1 mutants, further underlining a functional role of endogenous c-Src in the abrogation of growth factor dependence of hematopoietic cells.
Materials and methods

Cells
The GM-CSF-dependent human erythroleukemia cell line TF-1 was obtained from Kitamura (Kitamura et al., 1989) . TF-1 cells were cultured in RPMI 1640 medium (GIBCO-BRL, Eggenstein, Germany) supplemented with 10% (v/v) fetal calf serum (FCS) and 440 U/ml recombinant human GM-CSF (Leukomax; Sandoz, Nu¨rnberg, Germany). The factorindependent mutants have been established from TF-1 cells after cocultivation on irradiated amphotropic virus-producing cell lines and selection for growth factor independence in medium not supplemented with GM-CSF, as described earlier (Stocking et al., 1993) . After selection in medium without GM-CSF, the positive wells were recloned in agar cultures to isolate single, independent cell clones. In three independent experiments, a total number of more than 300 factor-independent mutants were isolated and further characterized (Stocking et al., 1993) . By analysing the supernatant of these clones for stimulating activity for the proliferation of the parental TF-1 cell line, the mutants were subdivided into two groups. One group of mutants released a growth factor that stimulated the growth of the parental TF-1 cell line and a second group of mutants which were called autonomous mutants which did not release any detectable growth-stimulating activity for TF-1 cells (Stocking et al., 1993) . From the group of autonomous mutants, the following clones have been selected for the experiments described in this study: I2b, I3-1, I10-1, I15-3, I16-3, I23-1, I26-4, I33-5, II17, II25, II40c, III1-13, III2-3, IIING1-3, IIING1-8, IIING1-13, IIING1-25. The factor-independent mutants were cultured in RPMI 1640 medium (GIBCO-BRL, Eggenstein, Germany) supplemented with 10% (v/v) FCS without GM-CSF. In addition, TF-1 cells were infected with the same pseudotyped retrovirus as described above, however, without selection for factor independence. From this mass culture grown in the presence of GM-CSF, a factordependent clone (TF-1 PAP10#5) has been obtained by agar cloning and used as a control as indicated in the figure legends. Mononuclear cells from bone marrow or peripheral blood from healthy donors were fractionated by gradient centrifugation using Histopaque-1077 according to the manufacturer (Sigma, St Louis, MO, USA).
Stimulation of cells
TF-1 cells or factor-independent mutants from TF-1 were starved for 18 h in RPMI 1640 medium containing 0.1%. (w/v) bovine serum albumin (BSA) (fraction V; Sigma, Deisenhofen, Germany) at a cell density of 5 Â 10 5 cells/ml. Cells were then resuspended in the same starvation medium at a cell density of 1 Â 10 7 cells/ml and were incubated at 371C in the absence or presence of 1000 U/ml recombinant human GM-CSF for 5 min. After incubation, cells were diluted into cold phosphate-buffered saline containing 1 mm sodium orthovanadate and cell lysates were prepared as described below.
Southern blot and Northern blot analysis
Isolation of genomic DNA, Southern blotting, isolation of total cytoplasmic RNA and Northern blotting were performed as described previously (Ju¨cker et al., 1991 . Total RNA (20 mg) was separated in formaldehyde-containing gels and stained with ethidium bromide to verify the integrity of the RNA and that equal amounts of RNA were loaded per lane. RNA was transferred on nylon membranes (Nytran; Schleicher & Schuell) and filters were hybridized overnight at 421C with cDNA probes labeled by random hexanucleotide priming (Amersham, Braunschweig, Germany). After washing, the filters were exposed to X-RAY RX films (Fuji, Du¨sseldorf, Germany) with an intensifying screen. Size of the mRNAs was estimated by using an RNA marker (RNA ladder; Gibco-BRL). For hybridization experiments, a human c-src cDNA was used which was cloned from TF-1 cells by RT-PCR as described below.
RT-PCR and mutational analysis
cDNA of human c-src mRNA was prepared by reverse transcription of 1 mg total RNA by using oligodT as primer and 2 U of Superscript reverse transcriptase (Gibco BRL, Eggenstein, Germany). Polymerase chain reaction (PCR) was performed with the following c-src specific primers: 5 0 -GCGGGAATTCTGGCCGGTGGAGTGACCACCTTTGT GG-3 0 as forward primer and 5 0 -GAGCAAGCTTCAAGCC GAGAAGCCGGTCTGGGCCCGCC-3 0 as reverse primer. PCR products were subcloned and five individual clones were sequenced. All sequences were aligned to the human wild-type sequence of c-src (NCBI GenBank Accession number NM_005417).
Preparation of cell lysates
Cells were lysed in Nonidet s P40 (NP 40) lysis buffer consisting of 50 mm N-2-hydroxyethylpiperazine-N 0 -2-ethanesulfonic acid (HEPES), pH 7.4,. 150 mm NaCl, 1% (v/v) NP 40, 2 mm EDTA, 10% (v/v) glycerol, 50 mm sodium fluoride, 10 mm sodium pyrophosphate, 1 mm sodium orthovanadate, 1 mm Pefabloc s (4-(2-aminoethyl)-benzenesulfonyl fluoride hydrochloride, Boehringer Mannheim, Mannheim, Germany), 200 KIU/ml Aprotinin (ICN, Eschwege, Germany) and 1 mm phenylmethylsulfonyl fluoride (Sigma). Protein concentration was determined using the detergent-compatible BioRad protein assay according to the manufacturer (BioRad, Mu¨nchen, Germany), and cell lysates were stored in liquid nitrogen until used.
Antibodies and immunoblotting
Cell lysates were analysed by SDS-PAGE and Western blot analysis as described, previously (Areces et al., 1994; Ju¨cker and Feldman, 1995) . Monoclonal antibodies against Src (mAb327) were kindly provided by Dr J Bolen (Lipsich et al., 1983) . For immunoblotting, different antisera were used which are directed against the b c of the GM-CSF receptor (SC675), Sam68 (SC333) MAP-kinase (Erk2) (SC154) from Santa Cruz Biotechnology, Heidelberg, Germany, antibodies directed against Jak2 and phosphotyrosine (4G10) from UBI, Lake Placid, USA and antibodies specific for Akt phosphorylated on serine residue 473 or antibodies which detect Akt independently of its phosphorylation state were purchased from New England BioLabs (Beverly, MA, USA). For immunoprecipitation, antibodies which are directed against the b c of the GM-CSF receptor (SC457) and MAP-kinases (SC154) from Santa Cruz Biotechnology Inc., Heidelberg, Germany and against Jak2 from UBI, Lake Placid, USA were used. Monoclonal antibodies recognizing Fes (MON-9.1) were kindly provided by Dr WJM Van de Ven (van Bokhoven et al., 1992) . Secondary antibodies directed against rabbit or goat immunoglobulin coupled to horse radish peroxidase were purchased from Santa Cruz Biotechnology. Filters were developed using the ECL system according to the manufacturer (Amersham, Braunschweig, Germany). Reprobing of nitrocellulose membrane was performed after antibodies were removed from the nitrocellulose membrane by incubation in stripping buffer (62.5 mm Tris, pH 6.7, 2% SDS and 100 mm bmercaptoethanol) for 30 min at 701C.
Immune complex kinase assay
Immune complex kinase assays were performed as described previously (Ju¨cker et al., 1997b) . Shortly, Src was immunoprecipitated from 2 mg cell lysate with the monoclonal antibody mAb327 and incubated in kinase buffer (50 mm HEPES, pH 7.4; 50 mm NaCl, 5 mm MgCl 2 , 5 mm MnCl 2 , 0.1 mm sodium orthovanadate, 0.3 mm [g-32 P]ATP) for 30 min at RT. The reaction was stopped by the addition of loading buffer and samples were separated by SDS-PAGE. Gel slices containing 32 P-labeled Src were cut out and measured in a bcounter.
Electrophoretic mobility shift assay (EMSA)
EMSA was performed as described in detail previously (Meyer et al., 1998) . Shortly, cells were resuspended in hypotonic buffer and lysed by 20 strokes in a glass Dounce homogenizer. Nuclei were collected by centrifugation and frozen in liquid nitrogen. Nuclear proteins were extracted with a hypertonic buffer and protein concentration determined. Of each cell mutant analysed, 1.2 mg nuclear extract was incubated for 30 min with 16 fmol end-labeled oligonucleotide. Reaction products were analysed by electrophoresis in a 6% polyacrylamide gel and autoradiography. The STAT5 binding site of the bovine b-caseine promoter was used as a probe. The specificity of the STAT5 proteins was shown in separate experiments by supershifting the oligonucleotide-bound STAT5 with 2 mg of an anti-STAT5 antibody (N20, Santa Cruz Biotechnology). Abbreviations SH2, src homology 2; GM-CSF, granulocyte-macrophage colony-stimulating factor; IL-3, interleukin-3; BM, bone marrow; PBMC, peripheral blood mononuclear cells; FCS, Increased Src kinase activity in factor-independent mutants S Horn et al fetal calf serum; SDS, sodium dodecyl sulfate; PAGE, polyacrylamide gel electrophoresis.
